World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
61
Citations
10742
World Ranking
1920
National Ranking
58

Amina Zoubeidi publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Amina Zoubeidi sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 201 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Amina Zoubeidi D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Amina Zoubeidi sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 61 D-Index — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Amina Zoubeidi is affiliated with the University of British Columbia in Canada. Their research primarily focuses on prostate cancer, encompassing treatment, diagnosis, and underlying molecular mechanisms. They have contributed extensively to understanding epigenetics, DNA methylation, and PARP inhibition in cancer therapy, among other related biological processes.

The scientist's work spans the fields of Medicine and Biochemistry, Genetics, and Molecular Biology, with a significant number of publications also pertaining to subfields including Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology, and Endocrinology, Diabetes, and Metabolism.

Their recent publications include the following notable papers:

  • The DNA methylation landscape of advanced prostate cancer, 2020, Nature Genetics
  • Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer, 2021, Nature Communications
  • An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer, 2021, Nature Cell Biology
  • Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1, 2020, Proceedings of the National Academy of Sciences
  • ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer, 2022, Nature Communications

Frequent publication venues for Amina Zoubeidi include:

  • Cancer Research
  • Nature Communications
  • Cell Reports
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Discovery

Their frequent co-authors, reflecting ongoing collaboration, include:

  • Himisha Beltran
  • Martin Gleave
  • Shaghayegh Nouruzi
  • Olena Sivak
  • Dwaipayan Ganguli

Main topics addressed in their research are:

  • Prostate Cancer Treatment and Research
  • Ubiquitin and proteasome pathways
  • Epigenetics and DNA Methylation
  • Prostate Cancer Diagnosis and Treatment
  • PARP inhibition in cancer therapy
  • Cancer, Lipids, and Metabolism
  • Cancer-related gene regulation

Best Publications

  • Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.

    David A. Quigley;Ha X. Dang;Shuang G. Zhao;Paul Lloyd

  • The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer.

    Jennifer L Bishop;Daksh Thaper;Daksh Thaper;Sepideh Vahid;Sepideh Vahid;Alastair Davies

  • Cellular plasticity and the neuroendocrine phenotype in prostate cancer

    Alastair H Davies;Himisha Beltran;Amina Zoubeidi;Amina Zoubeidi

  • Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19

    Junjie Tony Hua;Junjie Tony Hua;Musaddeque Ahmed;Haiyang Guo;Yuzhe Zhang;Yuzhe Zhang;Yuzhe Zhang

  • Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity.

    Amina Zoubeidi;Anousheh Zardan;Eliana Beraldi;Ladan Fazli

  • The role of lineage plasticity in prostate cancer therapy resistance

    Himisha Beltran;Andrew Hruszkewycz;Howard I. Scher;Jeffrey Hildesheim

  • PD-L1 is highly expressed in Enzalutamide resistant prostate cancer

    Jennifer L. Bishop;Alexander Sio;Arkhjamil Angeles;Morgan E. Roberts

  • The DNA methylation landscape of advanced prostate cancer

    Shuang G. Zhao;Shuang G. Zhao;William S. Chen;William S. Chen;Haolong Li;Adam Foye

  • The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer

    Shusuke Akamatsu;Alexander W. Wyatt;Dong Lin;Summer Lysakowski

  • Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate cancer.

    Masaki Shiota;Jennifer L. Bishop;Ka Mun Nip;Anousheh Zardan

  • Small heat shock proteins in cancer therapy and prognosis.

    Amina Zoubeidi;Martin Gleave

  • From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer

    Anna V Lapuk;Chunxiao Wu;Alexander W Wyatt;Andrew McPherson;Andrew McPherson

  • ONECUT2 is a driver of neuroendocrine prostate cancer.

    Haiyang Guo;Xinpei Ci;Xinpei Ci;Musaddeque Ahmed;Junjie Tony Hua;Junjie Tony Hua

  • Targeting the PI3K/Akt pathway in prostate cancer: challenges and opportunities (review).

    Paul Toren;Amina Zoubeidi

  • Targeting the Cytoprotective Chaperone, Clusterin, for Treatment of Advanced Cancer

    Amina Zoubeidi;Kim Chi;Martin Gleave

  • Clusterin Mediates TGF-β–Induced Epithelial–Mesenchymal Transition and Metastasis via Twist1 in Prostate Cancer Cells

    Masaki Shiota;Anousheh Zardan;Ario Takeuchi;Masafumi Kumano

  • Erratum: Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer (Cell (2018) 174(3) (758–769.e9), (S0092867418308420) (10.1016/j.cell.2018.06.039))

    David A. Quigley;Ha X. Dang;Shuang G. Zhao;Paul Lloyd

  • Clusterin facilitates COMMD1 and I-κB degradation to enhance NF-κB activity in prostate cancer cells

    Amina Zoubeidi;Susan Ettinger;Eliana Beraldi;Boris Hadaschik

  • Clusterin as a therapeutic target

    Mark R Wilson;Amina Zoubeidi

  • Targeting Lyn regulates Snail family shuttling and inhibits metastasis

    D Thaper;S Vahid;K M Nip;I Moskalev

Frequent Co-Authors

Martin E. Gleave
Martin E. Gleave University of British Columbia
Ladan Fazli
Ladan Fazli University of British Columbia
Yuzhuo Wang
Yuzhuo Wang University of British Columbia
Himisha Beltran
Himisha Beltran Harvard University
Housheng Hansen He
Housheng Hansen He University of Toronto
Colin Collins
Colin Collins University of British Columbia
Colleen C. Nelson
Colleen C. Nelson Queensland University of Technology
Alexander W. Wyatt
Alexander W. Wyatt University of British Columbia
Kim N. Chi
Kim N. Chi BC Cancer Agency
Fan Zhang
Fan Zhang University of British Columbia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Molecular Biology in the USA can open doors to a variety of online degree programs and diverse career paths. For students interested in broadening their academic horizons, affordable online interdisciplinary studies degrees provide an excellent opportunity to combine biology with other fields such as data science, public health, or even business.

Graduates who wish to pursue roles outside traditional lab settings might consider careers in history or education. If you are curious about the potential earnings in the field of history, it's helpful to learn how much do historians make to understand the value of advanced historical studies.

With a scientific background, you could also explore library and information science. A library science degree equips you with research and organizational skills essential for managing scientific information.

If you are passionate about healthcare or communication disorders, earning one of the asha accredited online slp master's programs can lead to a rewarding career in speech-language pathology. These related degrees expand your options and can complement your knowledge in molecular biology.

Best Scientists Citing Amina Zoubeidi

Trending Scientists